{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T12:09:13Z","timestamp":1788610153621,"version":"build-2803163510"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>RASopathies represent a group of genetically heterogeneous developmental disorders caused by germline variants in genes regulating the RAS\/MAPK signalling pathway. These syndromes share overlapping clinical features, complicating diagnosis. Dysregulation of this pathway disrupts normal development and contributes to diverse phenotypic manifestations. In this study, we conducted a comprehensive clinico-genetic correlation analysis in a North Indian cohort to identify causative genetic variants. As an exploratory approach, we also applied bioinformatic tools to identify potential drug\u2013gene interactions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We enrolled 84 patients with clinical suspicion of RASopathy spectrum disorders. Whole exome sequencing (WES) was performed to detect pathogenic variants. Clinical data were systematically collected and analysed for genotype\u2013phenotype correlation. Potential therapeutic agents were queried using the Drug\u2013Gene Interaction database (DGIdb).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Pathogenic or likely pathogenic variants in RASopathy-related genes were identified in 46 cases, including 14 with neurofibromatosis. Two patients had variants of unknown significance (VUS) in\n                      <jats:italic>MAPK1<\/jats:italic>\n                      and\n                      <jats:italic>LZTR1<\/jats:italic>\n                      .\n                      <jats:italic>PTPN11<\/jats:italic>\n                      variants were detected in 12 patients, while variants in\n                      <jats:italic>LZTR1, MAP2K2, BRAF, NRAS, HRAS, RAF1, RIT1, SOS1,<\/jats:italic>\n                      and\n                      <jats:italic>SOS2<\/jats:italic>\n                      were found in 20 others. All identified variants were heterozygous missense mutations, consistent with autosomal dominant inheritance. The most common clinical features were short stature (64.7%), downslanting palpebral fissures (38.23%), and chest wall deformities (35.29%). A trend was observed for the association between PTPN11 and SOS1 variants and pulmonary stenosis, though not statistically significant due to the small cohort size. Unique phenotypic findings associated with different variants in RASopathy spectrum genes were noted. Exploratory DGIdb analysis highlighted candidate drug\u2013gene interactions that may inform future research directions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings underscore the clinical and genetic diversity of RASopathies in the Indian population and highlight the role of next-generation sequencing in early and accurate diagnosis. While exploratory drug\u2013gene interaction analysis provides hypothesis-generating insights, clinical translation requires rigorous validation in functional studies and clinical trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fgene.2025.1677143","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T22:10:17Z","timestamp":1762812617000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Germline activating sequence variations in RASopathy spectrum genes: genotype\u2013phenotype correlation in a North Indian cohort"],"prefix":"10.3389","volume":"16","author":[{"given":"Shifali","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshan","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitra","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parminder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratibha","family":"Bawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi Pratap Singh","family":"Bhadoriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrinali","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupriya","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inusha","family":"Panigrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/diagnostics15020142","article-title":"KRAS, NRAS, and BRAF hot-spot mutations in relation to sidedness of primary colorectal cancer: a retrospective cohort study","volume":"15","author":"Abdelgadir","year":"2025","journal-title":"Diagn. (Basel)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/ejhg.2017.65","article-title":"Genotype and phenotype spectrum of NRAS germline variants","volume":"25","author":"Altm\u00fcller","year":"2017","journal-title":"Eur. J. Hum. Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12881-020-0986-5","article-title":"Molecular and clinical studies in 107 Noonan Syndrome affected individuals with PTPN11 mutations","volume":"21","author":"Athota","year":"2020","journal-title":"BMC Med. Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/gim.2016.169","article-title":"Phenotypic predictors and final diagnoses in patients referred for RASopathy testing by targeted next-generation sequencing","volume":"19","author":"Bhoj","year":"2017","journal-title":"Genet. Med. Official J. Am. Coll. Med. Genet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/ajmg.a.61445","article-title":"Providing more evidence on LZTR1 variants in Noonan syndrome patients","volume":"182","author":"Chinton","year":"2019","journal-title":"Am. J. Med. Genet. A"},{"key":"B6","doi-asserted-by":"publisher","first-page":"D1068","DOI":"10.1093\/nar\/gkx1143","article-title":"DGIdb 3.0: a redesign and expansion of the drug-gene interaction database","volume":"46","author":"Cotto","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/ajmg.a.31156","article-title":"LEOPARD syndrome: clinical diagnosis in the first year of life","volume":"140","author":"Digilio","year":"2006","journal-title":"Am. J. Med. Genet. Part A"},{"key":"B8","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1159\/000331266","article-title":"RASopathies: clinical diagnosis in the first year of life","volume":"1","author":"Digilio","year":"2011","journal-title":"Mol. Syndromol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1056\/NEJMoa1605943","article-title":"Activity of selumetinib in neurofibromatosis type 1-Related plexiform neurofibromas","volume":"375","author":"Dombi","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"D1144","DOI":"10.1093\/nar\/gkaa1084","article-title":"Integration of the drug-gene interaction database (DGIdb 4.0) with open crowdsource efforts","volume":"49","author":"Freshour","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1056\/NEJMoa1912735","article-title":"Selumetinib in children with inoperable Plexiform neurofibromas","volume":"382","author":"Gross","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"dmm049107","DOI":"10.1242\/dmm.049107","article-title":"The RASopathies: from pathogenetics to therapeutics","volume":"15","author":"Hebron","year":"2022","journal-title":"Dis. Models and Mech."},{"key":"B13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1136\/jmg.2005.040352","article-title":"Genotype-Phenotype correlation in Costello Syndrome: HRAS mutation analysis in 43 cases","volume":"43","author":"Kerr","year":"2006","journal-title":"J. Med. Genet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1038\/gim.2016.32","article-title":"Genotype and phenotype in patients with Noonan Syndrome and a RIT1 mutation","volume":"18","author":"Kouz","year":"2016","journal-title":"Genet. Med. Official J. Am. Coll. Med. Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/bjc.2015.75","article-title":"Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes","volume":"112","author":"Kratz","year":"2015","journal-title":"Br. J. Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s13312-021-2092-y","article-title":"Mutation and phenotypic spectrum of patients with RASopathies","volume":"58","author":"Lallar","year":"2021","journal-title":"Indian Pediatr."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.jpeds.2011.05.024","article-title":"Spectrum of mutations in Noonan Syndrome and their correlation with phenotypes","volume":"159","author":"Lee","year":"2011","journal-title":"J. Pediatr."},{"key":"B18","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","article-title":"Fast and accurate long-read alignment with burrows-wheeler transform","volume":"26","author":"Li","year":"2010","journal-title":"Bioinforma. Oxf. Engl."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/ng2073","article-title":"Gain-of-Function RAF1 mutations cause noonan and LEOPARD syndromes with hypertrophic cardiomyopathy","volume":"39","author":"Pandit","year":"2007","journal-title":"Nat. Genet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/humu.23175","article-title":"Structural, functional, and clinical characterization of a novel PTPN11 mutation cluster underlying Noonan Syndrome","volume":"38","author":"Pannone","year":"2017","journal-title":"Hum. Mutat."},{"key":"B21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev-genom-091212-153523","article-title":"The RASopathies","volume":"14","author":"Rauen","year":"2013","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and Guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and genomics and the Association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med. Official J. Am. Coll. Med. Genet."},{"key":"B23","first-page":"1993","article-title":"Noonan syndrome","volume-title":"GeneReviews\u00ae","author":"Roberts","year":"2001"},{"key":"B24","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0140-6736(12)61023-X","article-title":"Noonan Syndrome","volume":"381","author":"Roberts","year":"2013","journal-title":"Lancet London, Engl."},{"key":"B25","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1542\/peds.2009-3207","article-title":"Noonan Syndrome: Clinical Features, Diagnosis, and Management Guidelines","volume":"126","author":"Romano","year":"2010","journal-title":"Pediatrics"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1074\/jbc.RA119.010838","article-title":"A cellular target engagement assay for the characterization of SHP2 (PTPN11) phosphatase inhibitors","volume":"295","author":"Romero","year":"2020","journal-title":"J. Biol. Chem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e23685","DOI":"10.1016\/j.heliyon.2023.e23685","article-title":"Neurofibromatosis type 1: clinical characteristics and mutation spectrum in a north Indian cohort","volume":"10","author":"Srivastava","year":"2024","journal-title":"Heliyon"},{"key":"B28","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/ng772","article-title":"Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan Syndrome","volume":"29","author":"Tartaglia","year":"2001","journal-title":"Nat. Genet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/ajmg.c.32012","article-title":"The molecular genetics of RASopathies: an update on novel disease genes and new disorders","volume":"190","author":"Tartaglia","year":"2022","journal-title":"Am. J. Med. Genet. Part C, Seminars Med. Genet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/gim.2017.210","article-title":"Modeling the ACMG\/AMP Variant Classification Guidelines as a bayesian classification framework","volume":"20","author":"Tavtigian","year":"2018","journal-title":"Genet. Med. Official J. Am. Coll. Med. Genet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40142-016-0100-7","article-title":"Expansion of the RASopathies","volume":"4","author":"Tidyman","year":"2016","journal-title":"Curr. Genet. Med. Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/nprot.2015.105","article-title":"Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR","volume":"10","author":"Yang","year":"2015","journal-title":"Nat. Protoc."},{"key":"B33","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/ajmg.c.31692","article-title":"Genetic landscape of RASopathies in Chinese: three decades\u2019 experience in Hong Kong","volume":"181","author":"Yu","year":"2019","journal-title":"Am. J. Med. Genet. Part C, Seminars Med. Genet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jpeds.2003.11.032","article-title":"Genotype-Phenotype correlations in Noonan Syndrome","volume":"144","author":"Zenker","year":"2004","journal-title":"J. Pediatr."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1136\/archdischild-2021-322858","article-title":"Noonan Syndrome: improving recognition and diagnosis","volume":"107","author":"Zenker","year":"2022","journal-title":"Archives Dis. Child."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1677143\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T22:10:18Z","timestamp":1762812618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1677143\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":35,"alternative-id":["10.3389\/fgene.2025.1677143"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2025.1677143","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"article-number":"1677143"}}